Yokochi; Shoji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yokochi; Shoji.The latest application filed is for "hmgn partial peptide and cancer therapy using the same".

Company Profile

2.10.13

Yokochi; Shoji - Tokyo JP
Yokochi; Shoji - Inabe-gun JP
Yokochi; Shoji - Nagoya JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for reducing side effects of immune checkpoint control agent Grant 11,168,137 - Ito , et al. November 9, 2	2021-11-09
Hmgn Partial Peptide And Cancer Therapy Using The Same App 20200407408 - MATSUSHIMA; Kouji ; et al.	2020-12-31
Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient Grant 10,746,726 - Matsushima , et al. A	2020-08-18
Therapeutic Agent For Solid Cancer App 20190125867 - ITO; Satoru ; et al.	2019-05-02
Method For Assessing Therapeutic Effect Of Anti-cancer Agent Having Anti-cd4 Antibody As Active Ingredient App 20170328887 - MATSUSHIMA; Kouji ; et al.	2017-11-16
Therapeutic Agent For Solid Cancer App 20170165364 - ITO; Satoru ; et al.	2017-06-15
Method For Reducing Side Effects Of Immune Checkpoint Control Agent App 20170145099 - ITO; Satoru ; et al.	2017-05-25
Therapeutic Or Prophylactic Agent For Immunodeficiency Virus Infection App 20160108122 - ITO; Satoru ; et al.	2016-04-21
Antagonists of MCP-1 function and methods of use thereof Grant 7,297,696 - Laborde , et al. November 20, 2	2007-11-20
Antagonists of MCP-1 function and methods of use thereof Grant 6,998,407 - Laborde , et al. February 14, 2	2006-02-14
Antagonists of MCP-1 function and methods of use thereof Grant 6,992,086 - Laborde , et al. January 31, 2	2006-01-31
Antagonist of MCP-1 function, and compositions and methods of use thereof Grant 6,962,926 - Laborde , et al. November 8, 2	2005-11-08
Antagonists of MCP-1 function and methods of use thereof App 20050054668 - Laborde, Edgardo ; et al.	2005-03-10
Antagonists of MCP-1 function and methods of use thereof Grant 6,809,113 - Laborde , et al. October 26, 2	2004-10-26
Antagonist of MCP-1 function, and compositions and methods of use thereof App 20040198719 - Laborde, Edgardo ; et al.	2004-10-07
Antagonists of MCP-1 function and methods of use thereof App 20040127513 - Laborde, Edgardo ; et al.	2004-07-01
Antagonists of MCP-1 function and methods of use thereof App 20040077680 - Laborde, Edgardo ; et al.	2004-04-22
Antagonists of MCP-1 function and methods of use thereof Grant 6,677,365 - Laborde , et al. January 13, 2	2004-01-13
Antagonists of MCP-1 function and methods of use thereof Grant 6,670,364 - Laborde , et al. December 30, 2	2003-12-30
Antagonists of MCP-1 function and methods of use thereof App 20030105085 - Laborde, Edgardo ; et al.	2003-06-05
Antagonists of MCP-1 function and methods of use thereof App 20030096705 - Laborde, Edgardo ; et al.	2003-05-22
Antagonists of MCP-1 function and methods of use thereof App 20030092728 - Laborde, Edgardo ; et al.	2003-05-15
Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof Grant 5,869,460 - Usui , et al. February 9, 1	1999-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.